Worth reading
53Recurring
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
137500000
¥Wording
Definitive
How definitive the wording is.Details of issuance or disposal
Finalization of terms for the issuance of stock options (share acquisition rights)
Intended allottee
Category Directors of the company / Number of Employees 3 / Number of stock acquisition rights 3,350, Category The Company's employees / Number of Employees 6 / Number of stock acquisition rights 1,200, Category Employees of wholly owned subsidiaries of the Company / Number of Employees 5 / Number of stock acquisition rights 450 rights
Total issue value
¥137,500,000 (total issue price of the shares to be issued upon exercise of the share acquisition rights)
Terms of the stock acquisition rights
Exercise price
Initial exercise price: ¥275 per share (¥2.75 per share acquisition right). Adjustment provisions and adjustment floor: Not disclosed
Number of Stock Acquisition Rights
Total issued: 5,000 (3,350 + 1,200 + 450). Unexercised balance: Not disclosed
Categories and Number of Persons Covered
Category Directors of the company / Number of Employees 3 / Number of allocated stock acquisition rights 3,350, Category The Company's employees / Number of Employees 6 / Number of allocated stock acquisition rights 1,200, Category Employees of wholly owned subsidiaries of the Company / Number of Employees 5 / Number of allocated stock acquisition rights 450 rights
Procedures under the Corporate Code of Conduct
At the 40th Annual General Meeting of Shareholders held on 27 June 2025, the proposal concerning the issuance of share acquisition rights as stock options was approved and adopted
| Item | Details |
|---|---|
| Type of issuance or disposal | Finalization of terms for the issuance of stock options (share acquisition rights) |
| Total issue value | ¥137,500,000 (total issue price of the shares to be issued upon exercise of the share acquisition rights) |
| Intended allottee | Category Directors of the company / Number of Employees 3 / Number of stock acquisition rights 3,350, Category The Company's employees / Number of Employees 6 / Number of stock acquisition rights 1,200, Category Employees of wholly owned subsidiaries of the Company / Number of Employees 5 / Number of stock acquisition rights 450 rights |
| Exercise price | Initial exercise price: ¥275 per share (¥2.75 per share acquisition right). Adjustment provisions and adjustment floor: Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 5,000 (3,350 + 1,200 + 450). Unexercised balance: Not disclosed |
| Categories and Number of Persons Covered | Category Directors of the company / Number of Employees 3 / Number of allocated stock acquisition rights 3,350, Category The Company's employees / Number of Employees 6 / Number of allocated stock acquisition rights 1,200, Category Employees of wholly owned subsidiaries of the Company / Number of Employees 5 / Number of allocated stock acquisition rights 450 rights |
| Procedures under the Corporate Code of Conduct | At the 40th Annual General Meeting of Shareholders held on 27 June 2025, the proposal concerning the issuance of share acquisition rights as stock options was approved and adopted |
Items this document does not state (21)
Number of shares to be issued or disposed ofIssue price and disposal priceAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The previously undetermined terms were finalized based on approval at the Annual General Meeting of Shareholders held on 27 June 2025 and a resolution of the Board of Directors adopted on 25 May 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.